Evaluation of the Neonatal Autonomic Stress During Intubations Under

Status Completed

Clinical Trial Summary

Hyaline membrane disease is one of the leading causes of morbidity and mortality in premature newborns in industrialized countries. For 30 years, the management of the hyaline membranes disease has been transformed by intratracheal administration of exogenous surfactant (Curosurf®) at birth or in the following hours. In order to limit the harmful effects in terms of barotrauma of mechanical ventilation, several methods have been developed over the last decades, aiming at limiting the mechanical ventilation to the profile of non-invasive ventilation: Thus the administration of surfactant has become faster (although invasive) and if possible followed by immediate extubation following the INSURE (INtubation / SURfactant / Extubation) or LISA (Less-Invasive Surfactant Administration) procedure. Given the fragility of the children concerned and their low weight, this invasive gesture has long been carried out without premedication. However, taking into account the pain induced and potential hemodynamic consequences of the gesture, neonatal societies now recommend the use of anesthetic before intubation, with a short duration sedative. Propofol is a general anesthetic that combines these conditions and is widely used in pediatric anesthesia. In that way, since 2016, the invetigators have modified the sedation protocol for intubation in our department and have recommended Propofol as first-line treatment for term and preterm newborn. A lot of study showed its hemodynamic safety in preterms. However, the investigators lack data on the autonomic stress really observed during intubation in this population. The investigators therefore propose to evaluate these physiological data in a non-randomized prospective observational study in premature infants under 33 weeks of gestational amenorrhea (GA), during a sedation protocol for intubation and surfactant administration according the INSURE or LISA technique, with standardized doses of propofol : 1mg/kg for preterm infants with a birthweight less than 1.5kg and 1.5mg/kg for higher birthweight.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03721640
Study type	Observational
Source	Centre Hospitalier Universitaire de Saint Etienne
Contact
Status	Completed
Phase
Start date	February 25, 2019
Completion date	August 23, 2022

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04062513` - Olfactive Stimulation Interventions With Mothers' Milk on Preterm Pain Response	N/A
Completed	`NCT03412578` - Effect of Tactile/Kinaesthetic Massage Therapy on DXA Parameter of Preterm Infants	N/A
Completed	`NCT03166722` - Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition	N/A
Enrolling by invitation	`NCT03212547` - The Effect of a Neonatologist's Standardized Guidance Intervention on Preterm Infants With Relational Withdrawal.	N/A
Completed	`NCT03931902` - The Comparison of Laryngeal Mask Airway and Endotracheal Tube in General Anesthesia for Premature Neonates	N/A
Completed	`NCT03302000` - Visual Stimulation of Preterm Infants	N/A
Completed	`NCT03731546` - Effect of Delayed Cord Clamping in Preterm Neonates With Placental Insufficiency	N/A
Completed	`NCT03104946` - To Research the Relation Between Neonatal Morbidities and Poor Outcome in Preterm Infants	N/A
Completed	`NCT03704012` - Efficacy of Massage Applied by the Parents in Hospitalized Premature Birth (PreMas)	N/A
Suspended	`NCT03220282` - The Milk, Growth and Microbiota Study	N/A
Active, not recruiting	`NCT03232931` - Trial to Improve Multisensory Neural Processing, Language & Motor Outcomes in Preterm Infants	N/A
Completed	`NCT03242057` - Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA	N/A
Completed	`NCT04089540` - New Intubation Method to Achieve Circulatory Stability and to Reduce Number of Intubation Attempts in Neonates	N/A
Not yet recruiting	`NCT02528851` - Cardiorespiratory Effects of "Higher" Versus "Equivalent" CPAP Upon Extubation From High EAP in Preterm Infants	N/A
Completed	`NCT01959737` - Delivery Room Skin-to-skin Study	N/A
Completed	`NCT03700463` - Executive Functions and Preterm Children in 3 to 4 Year Old
Completed	`NCT02811432` - Kangaroo Mother Care Before Stabilisation Amongst Low Birth Weight Neonates in Africa	N/A
Completed	`NCT03728764` - Growth and Safety of a Two-stage Feeding System in Preterm Infants	N/A
Completed	`NCT04382976` - The Incidence and the Risk Factors of Nephrocalcinosis in Very Preterm Infants
Completed	`NCT03748914` - C-UCM and Cerebral Oxygenation and Perfusion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of the Neonatal Autonomic Stress During Intubations Under Propofol in a Population of Premature Infants Under 33 w'GA — PROPOSURF

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms